Rye Brook Capital »

SPDR S&P Biotech shares owned by Rye Brook Capital

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Rye Brook Capital from 13F filings

Historical chart of Rye Brook Capital investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Rye Brook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Rye Brook Capital

Quarter filed Position value Share count Share price at filing
2026-09-30 $205k 1.3k 157.69
2021-03-31 $3.1M 23k 135.67
2020-12-31 $2.6M 18k 140.77

More positions owned by Rye Brook Capital

Invesco Qqq Trust Series 1 Etf (QQQ)
Sprott Physical Uranium Tr Etf (SRUUF)
Vaneck Semiconductor Etf Etf (SMH)
Ss Industrial Select Sector Etf (XLI)
Vaneck Pharmaceutical Etf Etf (PPH)
Kraneshares Csi China Intern Etf (KWEB)
Nexgen Energy (NXE)
St Sr Utl Sl Se Spdr Etf-usd Etf (XLU)
Spdr Gold Shares Etf (GLD)
Ss Materials Select Sector Etf (XLB)
Grayscale Ethereum Staking M Etf (ETH)
Ss Financial Select Sector Etf (XLF)
Bloom Energy Corp (BE)
St. Joe Company (JOE)
Amazon (AMZN)

View all positions for Rye Brook Capital

Top funds holding SPDR S&P Biotech

Bnp Paribas Arbitrage, Snc
Goldman Sachs Group
Bank of America Corporation
Jane Street
Healthcare Of Ontario Pension Plan Trust Fund
Susquehanna International
Citadel Advisors
Wells Fargo & Company
UBS Group
Peak6
Barclays
Millennium Management
Leucadia National Corporation
Jpmorgan Chase & Co
Canada Pension Plan Investment Board

View all funds holding SPDR S&P Biotech